JPS6461416A - Antidepressant - Google Patents

Antidepressant

Info

Publication number
JPS6461416A
JPS6461416A JP21586487A JP21586487A JPS6461416A JP S6461416 A JPS6461416 A JP S6461416A JP 21586487 A JP21586487 A JP 21586487A JP 21586487 A JP21586487 A JP 21586487A JP S6461416 A JPS6461416 A JP S6461416A
Authority
JP
Japan
Prior art keywords
compound
formula
active component
cyclohexane derivative
antidepressant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP21586487A
Other languages
Japanese (ja)
Inventor
Toshiaki Shiyou
Hiroshi Shinyama
Yasuhiko Fujita
Masakazu Iwai
Masahiro Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Priority to JP21586487A priority Critical patent/JPS6461416A/en
Publication of JPS6461416A publication Critical patent/JPS6461416A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To provide an antidepressant containing a cyclohexane derivative as an active component, having antidepressing action, useful for the remedy of depression of mammal (human, horse, dog, etc.) and applicable by oral or parenteral administration. CONSTITUTION:A cyclohexane derivative of formula I (R is alkyl; R<1> and R<2> are H or organic residue) is used as an active component of the objective antidepressant. It can be administered orally or parenterally. In the case of oral administration, the cyclohexane derivative is properly mixed with a pharmacologically allowable additive (e.g. carrier, excipient or diluent) and used in the form of powder, tablet, capsule, troche, solution, etc. In the case of parenteral administration, the compound is used as intravenous or intramuscular injection, suppository, etc., in the form of an aqueous solution or nonaqueous suspension. The daily dose of the active component is preferably about 0.01-1mg for adult. The compound of formula I is e.g. the compound of formula II.
JP21586487A 1987-08-29 1987-08-29 Antidepressant Pending JPS6461416A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21586487A JPS6461416A (en) 1987-08-29 1987-08-29 Antidepressant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21586487A JPS6461416A (en) 1987-08-29 1987-08-29 Antidepressant

Publications (1)

Publication Number Publication Date
JPS6461416A true JPS6461416A (en) 1989-03-08

Family

ID=16679535

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21586487A Pending JPS6461416A (en) 1987-08-29 1987-08-29 Antidepressant

Country Status (1)

Country Link
JP (1) JPS6461416A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060177381A1 (en) * 2002-02-15 2006-08-10 Howard Brooks-Korn Opiopathies

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060177381A1 (en) * 2002-02-15 2006-08-10 Howard Brooks-Korn Opiopathies

Similar Documents

Publication Publication Date Title
KR890701562A (en) Immunomodulatory Azas Pirans
ATE109149T1 (en) 3-PYRROLIDINYLTHIO-1-AZABICYCLO(3.2.0&gt;-HEPT-2-E - 2-CARBONIC ACID COMPOUNDS.
OA09039A (en) 3-alkenyl-1-azabicyclo (3.2.0) hep-2-ene-2carboxylic acids
DE68916071T2 (en) 3-Pyrrolidinylthio-1-azabicyclo (3.2.0) hept-2-en-2-carboxylic acid compounds.
AU4218093A (en) New peptides derived from trifluoromethyl ketones, process for their preparation and the pharmaceutical compositions which contain them
ES8606336A1 (en) 2-(N-substituteguanidino)-4-hetero-arylthiazole antiulcer agents.
GR3017281T3 (en) Inhibitors of N-myristoyltransferase, their preparation process and pharmaceutical compositions containing them.
ES8705371A1 (en) Aminopropanol derivatives, process for their preparation, their use and medicines containing them.
JPS6452719A (en) Heterocyclic sulfide
NO168888C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF NEW, THERAPEUTICALLY APPLICABLE TETRAHYDROHV, respectively. Octahydro- (3,4&#39;-bi-2H-pyrrole) -2,2&#39;-dione
FI104071B1 (en) Analog Method for Preparation of Therapeutically Useful 2,5-Dihydro-2,5-Dioxo-1 H -benz [b] Azepine Derivatives
JPS6461416A (en) Antidepressant
ES8503676A1 (en) Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives.
EP0334967A4 (en) Keratosis-treating agent
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
ES8603829A1 (en) Medicines based on piperidine derivatives, piperidine derivatives and process for their preparation.
JPS5673046A (en) Decaprenylamine derivative
AR247737A1 (en) Cycloalkylthiazole derivatives
SE7412163L (en)
JPS6485915A (en) Hypotensor
ES8604122A1 (en) 2-(phenylmethylene)-1-(diaminoalkoxy) cycloalkanes and their pharmaceutical uses
SE8804696L (en) DIOXAZOCIN DERIVATIVES, THEIR PREPARATION AND PREPARATIONS CONTAINING THEM
ES8603824A1 (en) Carboxylic acid amide compounds and their derivatives
FR2334351A1 (en) 3-Thiomethyl-2(2-(dialkylamino)ethyl)indoles
ATE92461T1 (en) ACTIVE AGAINST CEREBRAL INSUFFICIENCY COMPOUNDS.